BRCA1 and ovarian carcinoma: [13], and the Dutch study did not report BRCA1/2 mutations in their study population [12], though others reported very significant regional differences in BRCA1/2 mutations even within this relatively small country [17]. The individual BRCA1/2 mutations in here reported ovarian cancer patients are reported in the Table 3, and also demonstrated no significant overlap with either Austrian or Italian studies.